DaVita Inc. Overview
Pro stress-test →DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States, operating kidney dialysis centers and providing related lab services in outpatient dialysis centers, as well as outpatient, hospital inpatient, and home-based hemodialysis services. The company has evolved from a volume-based dialysis operator into a sophisticated, value-based manager of integrated kidney care.
Strategic Profile
Pro stress-test →As of early February 2026, the company is being hailed as one of the top-performing large-cap stocks of the year. With a clarified regulatory horizon and massive share buybacks boosting earnings per share (EPS), DaVita has proven that the death of dialysis was greatly exaggerated. DaVita has embraced a collaboration with Elara Caring, paving ways into the kidney-specific, home-based care landscape and bolstering their intent to remain at the forefront of patient-specific healthcare solutions.
Competitive Landscape
Pro stress-test →With a market capitalization of $7.85 billion, DaVita operates within the healthcare sector, specifically in the healthcare providers & services industry. DaVita dominates the U.S. dialysis market with a network of kidney dialysis centers, competing against smaller regional dialysis providers and integrated healthcare systems. The company's competitive advantages include scale, integrated care capabilities, clinical expertise, and established relationships with nephrologists and payers.
Industry Context
DaVita Inc. operates in Healthcare Providers & Services - Dialysis and Kidney Care.
Key facts
Founded: 1994 · Headquarters: Denver, Colorado · Revenue: $13.65B · Market cap: $7.85B